Compared to healthy controls, patients with active IBD exhibit significant infiltration of Th17 cells in the intestinal mucosa, with elevated expression of Th17-related cytokines (including IL-17, IL-21, and IL-22) at inflammatory sites and in peripheral blood. This evidence concerns the gene IL22 and irritable bowel syndrome.